The Northwest Clinical Genomics Laboratory offers the latest technology in exome sequencing. Exome analysis can be used to identify disease-causing sequence variants in individual or extended families. Panel tests, developed by experts in medical genetics and target specialties are continually updated with the identification of new pathogenic genes. ACMG guidelines for incidental findings are instituted to allow families to learn about variants in medically actionable genes with pathogenic potential if they so choose.
The Northwest Clinical Genomics Laboratory offers full insurance pre-authorization services along with genetic counseling services. For more information, please visit the NCGL Test Page or click one of the links below.